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Introduction: Cardio-metabolic risk factors have been associatedwith poor physical andmental health. Epidemi-
ological studies have shown peripheral risk markers to be associated with poor cognitive functioning in normal
healthy population and in disease. The aim of the study was to explore the relationship between cardio-
metabolic risk factors and cortical thickness in a neurologically healthy middle aged population-based sample.
Methods: T1-weighted MRI was used to create models of the cortex for calculation of regional cortical thickness
in 40 adult males (average age = 50.96 years), selected from the pSoBid study. The relationship between
cardio-vascular risk markers and cortical thickness across the whole brain, was examined using the general
linear model. The relationship with various covariates of interest was explored.
Results: Lipid fractionswith greater triglyceride content (TAG, VLDL and LDL)were associatedwith greater cortical
thickness pertaining to a number of regions in the brain. Greater C reactive protein (CRP) and intercellular adhe-
sion molecule (ICAM-1) levels were associated with cortical thinning pertaining to perisylvian regions in the left
hemisphere. Smoking status and education status were signiﬁcant covariates in the model.
Conclusions: This exploratory study adds to a small body of existing literature increasingly showing a relationship
between cardio-metabolic risk markers and regional cortical thickness involving a number of regions in the
brain in a neurologically normal middle aged sample. A focused investigation of factors determining the inter-
individual variations in regional cortical thickness in the adult brain could provide further clarity in our under-
standing of the relationship between cardio-metabolic factors and cortical structures.
© 2013 The Authors. Published by Elsevier Inc.
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1. Introduction
Epidemiological studies have demonstrated a link between increasing
body mass index (BMI)—a commonly used index to deﬁne obesity, ele-
vated total cholesterol (TC), low-density lipoprotein cholesterol (LDL),
and triglycerides (TAG) and cerebrovascular and cardiovascular disease
(Denke et al., 1994; Krauss et al., 1998). While the above mentioned
risk factors are thought to drive the development and progression of
atherosclerosis, greater high-density lipoprotein (HDL) is thought to be
anti-atherogenic and therefore protective against these diseases (Toth,
2004). These “classic” cardiovascular risk factors have also been associat-
ed with poor physical, mental health and neuro-cognitive function (M.F.
Elias et al., 2005; P.K. Elias et al., 2005). Most studies that have examined
the relationship between these risk factors and the brain in healthy adults
have generally found an inverse association between the risk factors and
brain volume. Gunstad et al. in a large sample of 201 healthy individuals
using voxel based morphometry (VBM) analysis, found that obese
(BMI > 30) individuals had signiﬁcantly smaller whole brain and total
grey matter (GM) volume compared to normal and overweight individ-
uals (Gunstad et al., 2008). Raji et al using tensor-based morphometry
(TBM) in 94 elderly subjects found that obese subjects with a high BMI
(BMI > 30) showed atrophy in the frontal lobes, anterior cingulate
gyrus, hippocampus, and thalamus compared with individuals with a
normal BMI (18.5–25) (Raji et al., 2010). Studies that have examined
the relationship between cholesterol and grey matter are fewer and
have shown inconsistent results. For example, Ward et al. in a sample
of 183 individuals using VBM analysis did not ﬁnd any association
between non-HDL cholesterol and grey matter volume (Ward et al.,
2010). They however found a signiﬁcant positive correlation between
HDL cholesterol and regional GM volumes pertaining to bilateral tempo-
ral and occipital regions. More recent studies have suggested that the
relationship between these risk factors and brain morphology may be
more complex, particularly in relation to cortical thickness (CT)—a robust
measure that has been validated against histological analysis (Fischl et al.,
2008; Rosas et al., 2002).
In recent years, novel biomarkers associated with inﬂammation and
endothelial dysfunctions have ‘emerged’ as potential independent
cardiovascular disease risk factors (Umemura et al., 2011; Wersching
et al., 2010). These include high-sensitivity C-reactive protein
(hsCRP), an acute phase reactant protein, interleukin-6 (IL-6), a pro-
inﬂammatory cytokine and circulating forms of adhesion molecules
like intercellular adhesion molecule (ICAM)-1, that are induced by
inﬂammation and play a role in promoting atherosclerosis (Danesh
et al., 2008; Luc et al., 2003). These inﬂammatory markers have been
shown to be associated with poor cognitive functioning in the healthy
population and in disease (Phillips et al., 2011;Wright et al., 2006). Pro-
spective studies have shown such factors to predict cognitive decline in
initially healthy elderly subjects over follow-ups of between one and
ten years (Teunissen et al., 2003; Yaffe et al., 2003). Greater inﬂamma-
tory markers have also been shown in several psychiatric illnesses
like depression, and schizophrenia (Dowlati et al., 2010; Miller et al.,
2011). Although the precise role of these factors in neurocognitive func-
tion is not clear, there is evidence to suggest that inﬂammation may
play a role in the etiopathogenesis of mental and cognitive disorders
(Krishnadas and Cavanagh, 2012).
Other markers of haemostasis and endothelial function have also
been found to be independent predictors of coronary heart disease and
ischemic stroke. These include von Willebrand factor (vWF) and ﬁbrin-
ogen,which play an important role in platelet adhesion and aggregation,
and tissue plasminogen activator (tPA)—which plays an important role
in endogenous ﬁbrinolysis (Smith et al., 2005; Wannamethee et al.,
2012). They have been found to be signiﬁcant risk factors for vascular
dementia and cognitive impairment in older adults (Gallacher et al.,
2010; Quinn et al., 2011).
The potential aetiological links between cardio-metabolic risk
factors and brain structure and function need further exploration as
possible explanations for the relationship between the burden of phys-
ical andmental ill health. Key questions here are; is there a relationship
between vascular health and neural health? Are cardiovascular risk
markers potential endophenotypes for neuronal and hence psychiatric
illnesses? However, whether variance in risk markers in the healthy
adult population explains inter-individual differences in grey matter
correlates of neurocognitive function is not fully clear. The aim of this
study was to explore the relationship between various peripheral
blood markers of inﬂammation and cardio-metabolic risk and cortical
thickness (CT). We speciﬁcally examined if “classic risk factors” –
including blood lipid fractions, carotid intima-media thickness (CIMT)
and BMI, and “emerging” risk factors – including hs C-reactive protein
(CRP); inerleukin-6, (IL6); ﬁbrinogen; tissue plasminogen activator
(tPA) antigen and markers of endothelial dysfunction – intercellular
adhesion molecule (ICAM) and von Willebrand factor (vWF) – could
potentially explain inter-individual variance in cortical thickness
(Helfand et al., 2009).
2. Material and methods
2.1. Participants
Participants were recruited as part of a larger study (Psychological,
social and biological determinants of ill health (pSoBid) (http://www.
gcph.co.uk/work_programmes/psobid)(Knox et al., 2012; McGuinness
et al., 2012; McLean et al., 2012; Packard et al., 2011; Shiels et al.,
2011; Velupillai et al., 2008). Details of the design of pSoBid have been
described elsewhere (Deans et al., 2009; Velupillai et al., 2008). Brieﬂy,
selection of participants was based on the Scottish Index of Multiple
Deprivation 2004 (SIMD). Sampling was stratiﬁed to achieve an ap-
proximately equal distribution of the 666 participants across males
and females and age groups (35–44, 45–54 and 55–64 years) within
the most (bottom 5% of SIMD score) and least deprived areas (top 20%
of SIMD score). Participants could opt-in for the neuroimaging compo-
nent of the study. From a total of 327 male participants, 140
volunteered, and 42 (21 from least deprived and 21 frommost deprived
areas) of these were randomly selected. Individuals were excluded if
they had a history suggestive of neurological or serious psychiatric
illness. Participants with a history of cerebrovascular disease were
excluded from the study. They were also excluded if they had a history
of head injury or any contraindication for MRI. In addition, a consultant
neuroradiologist examined all the scans. None of the participants
included in the present study showed signiﬁcant pathology on the
scans. The present paper presents the results from the 40 individuals
who had the complete data on “classic” biomarkers and 39 who had
complete data on “emerging” risk factors, and structural MRI data.
2.2. Blood biochemical analysis
Ten to twelve hour fasting morning blood samples were collected,
separated and frozen at −80 °C within 1 h of venepuncture, except
for samples for high sensitivity C-reactive protein (CRP), which
were analysed on fresh plasma. High sensitivity C-reactive protein
(CRP) was measured by an immunoturbidimetric assay (Roche Diag-
nostics Ltd., Burgess Hill, United Kingdom) and had a coefﬁcient of
variation (CV) of less than 3%. Interleukin-6 (IL-6) and intercellular
adhesion molecule-1 (ICAM) were measured by sandwich ELISA
(R&D Systems Europe Ltd., Abingdon, United Kingdom). The between
batch CV for IL-6 was 8.3% at a concentration of 2.84 pg/mL and 10.0%
at 5.38 pg/mL. The between batch CV for sICAM-1 was 5.5% at an an-
alyte concentration of 190 ng/mL and 8.1% at 240 ng/mL. Fibrinogen
was measured on an automated coagulometer (MDA-180, Organon
Teknika, Cambridge, United Kingdom) with a between batch CV of
3.7% at a ﬁbrinogen concentration of 2.89 g/L. von-Willebrand factor
(vWF)wasmeasured using an in-house enzyme linked immunosorbent
assay (ELISA), employing rabbit anti-human polyclonal antibodies
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(DAKOUK Ltd, Ely, UK) andhad a between batch CV of 3.4% at 128 IU/dl.
Tissue plasminogen activator antigen (tPA) was measured by ELISA
(Hyphen, Neuville-sur-Oise, France) with a CV 6.5% at an analyte con-
centration of 4.42 ng/mL. Total cholesterol, triglycerides, low-density
lipoprotein (LDL), high-density lipoprotein (HDL), apolipoproteins
(Apos) A1 and B were analysed on fresh plasma. Their concentrations
were determined by enzymatic colorimetric assays on a Roche Hitachi
917 analyser (Roche Diagnostics Ltd, Burgess Hill, UK). Lipid fractions
were measured using ultracentrifugation and precipitation methods.
All the lipid analysis had a between batch CV of less than 3%.
2.3. Dimension reduction of lipid fractions
In order to reduce the number of dependent variables and to derive
factors representing broad domains within the markers that are statis-
tically independent, we subjected the raw scores from 6 measures of
lipid fraction including HDL, LDL, VLDL, trigycerides, Apo A1, Apo B, to
principal components analysis (PCA). The statistical independence of
the factors meant that the relationship of each factor to cortical thick-
ness was likely to estimate the speciﬁc association that each factor
had on CT. Varimax rotation was used and the minimum eigenvalue
for extractionwas set to one. The analysis revealed a set of 3 orthogonal
factors that explained a total of 95.7% of the variance. The ﬁrst factor
called “TAG” explained 38.4% of the variance with high loadings from
triglycerides and VLDL. The second factor was called an “LDL” factor,
which explained 29.79% of the variance, with high loadings from LDL
and Apo-B. The third factor was called an “HDL” factor and explained
27.5% of the variance with high loadings from HDL and Apo A1. Factor
scores were extracted using the regression method. These factors
were used as dependent variables in the general linear model (GLM)
model described below. A similar approach was attempted with the
“emerging” factors. However, the Bartlett's test of sphericity suggested
that the correlation matrix was an identity matrix, which implied that
the factor model was inappropriate. Therefore an exploratory analysis
of individual risk factors was performed separately.
2.4. Carotid intima-media thickness (CIMT) measurement
Carotid ultrasound scans were performed on an ACUSON Sequoia
512 Ultrasound System with an L7 5–12 MHz linear array broadband
transducer (Siemens Medical Solutions, Erlangen, Germany). The
details of the scan acquisitions have been published in detail previously
(Deans et al., 2009). Brieﬂy, the same research nurse, who was trained
in ultrasound techniques at the Department of Vascular Medicine,
Academic Medical Centre, Amsterdam, The Netherlands, performed
majority of the scans. As pre-speciﬁed in the study protocol, research
nurses performing ultrasonography were required to complete a mini-
mum of 10 paired replicate volunteer scans before scanning partici-
pants. The mean absolute difference for the mean common carotid
artery IMT measurement between nurses was 0.0542 mm, which was
well within the predeﬁned performance requirement for sonographer
certiﬁcation, with the requirement having been determined by the De-
partment of Vascular Medicine, Academic Medical Centre, Amsterdam,
to be a mean absolute difference of b0.15 mm, and was also within
the 88 more stringent requirements suggested by the American Society
of Echocardiography, who suggests a certiﬁcation requirement of a
mean absolute difference of b0.055 mm (Stein et al., 2008). Further
paired replicate scans of volunteers were performed at intervals
throughout the study to demonstrate continued fulﬁlment of the qual-
ity criteria. Both left and right common carotid arteries were assessed.
Intima-media thickness was measured on the far wall of each arterial
segment, averaged along a 1 cm length or as much as could be read.
The average of the left and right maximum common carotid IMT was
computed (van der Meer et al., 2004).
2.5. MRI acquisition
All MRI examinations were performed using GE Medical systems,
3T Signa Excite HD system (Milwaukee, USA) with an eight-channel
phased array (receive only) head coil. An axial 3D T1-weighted
IR-FSPGR was acquired with the following imaging parameters: TR =
6.8 ms; TE = 1.5 ms, inversion preparation time = 500 ms; ﬂip
angle = 12°; FOV = 26cm; phase FOV = 70%; matrix: 320 × 320;
bandwidth 31.25 kHz; number of slices = 160; Slab thickness =
1 mm. The acquisition time for this scan was 8 min 54 s.
2.6. Cortical thickness (CT) measurements and analysis
We used the method similar to that of Leritz et al. (2011), who
examined the association between cerebrovascular risk factors to CT
in a normative sample of community dwelling adults (Leritz et al.,
2011). Surface extraction, cortical parcellations and thickness computa-
tion were performed with the FreeSurfer image analysis suite. The
pre-processing was carried out according to documentation, which
has been validated and the description is available at (http://surfer.
nmr.mgh.harvard.edu/) (Dale et al., 1999; Fischl and Dale, 2000; Fischl
et al., 1999). Brieﬂy, following skull-stripping and correction of inhomo-
geneity artefact, constrained region growing was used to create a uni-
tary white matter volume for each hemisphere. The grey-matter/
white-matter boundary for each cortical hemisphere was determined
using tissue intensity and neighbourhood constraints. Thewhitematter
surface was tessellated by assigning 2 triangles to the square face of
each surface voxel. This process yielded approximately 160,000 vertices
per hemisphere. The white matter surfaces were deformed towards
the grey matter/pial boundary, with a point-to-point correspondence
at each vertex. CT was computed as the distance between the white
and the pial surfaces at each vertex. Cross-subject registration of
hemispheric cortical surfaces was performed by projecting them onto
the spherical representations. The maps produced are not restricted to
the voxel resolution of the original images and are thus capable of
detecting sub-millimetre differences between groups. Procedures for
themeasurement of CThave been validated against histological analysis
and manual measurements. In addition, FreeSurfer morphometric pro-
cedures have demonstrated good test–retest reliability across scanner
manufacturers and across ﬁeld strengths and across various sequence
parameters.
2.7. Statistical analysis
The procedure previously described by Leritz et al. was adopted
(Leritz et al., 2011). Statistical comparisons of global data and surface
maps were generated by computing a general linear model (GLM) of
the effects of each risk factor variable (independent variable) on
thickness (dependent variable) at each vertex in the cortical
mantle, using the Query, Design, Estimate, Contrast (QDEC) interface
of FreeSurfer. QDEC is a single-binary application included in the
FreeSurfer distribution that is used to perform group averaging and in-
ference on the cortical morphometric data produced by the FreeSurfer
processing stream (http://surfer.nmr.mgh.harvard.edu/fswiki/Qdec).
In case of the lipid fractions, the factors extracted from PCA were
entered as independent variables of interest. For BMI, CIMT and the
‘emerging’ factors, individual risk factors were entered as independent
variables of interest. Maps were created using statistical thresholds of
p = .05 and were smoothed to a full width half maximum (FWHM)
level of 20 mm. Since this analysis involved performing a GLM analysis
at 160,000 vertices, these maps were corrected for multiple compari-
sons by means of a cluster-wise procedure using the Monte Carlo
Null-Z simulation method adapted for cortical surface analysis and
incorporated into the QDEC processing stream. For these analyses, a
total of 10,000 iterations of simulation were performed for each com-
parison, using a threshold of p = .05. The simulation cluster analysis
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was run for thickness analyses with each independent variable sepa-
rately (Hagler et al., 2006; Leritz et al., 2011). There is considerable
debate on the distinction between exploratory and conﬁrmatory analy-
sis and whether exploratory analysis should be corrected for multiple
testing (Bender and Lange, 2001). Considering the fact that previous re-
sults have shown inconsistent relationships and that some of the bio-
markers we tested were novel, we considered our analysis to be
predominantly exploratory in nature. However, rather than use conser-
vative family wise error tests at this level, in order to adjust for explor-
ing the relationship between 11 different risk factors on CT, we took an
approach of exploring the strength of the signiﬁcance of the relation-
ship. Therefore, in the previous step, if the clusters survived the
Monte Carlo simulation at a threshold of 1.3 (p b 0.05), we repeated
the analysis at thresholds of 2.0 and 2.3 corresponding to p values of
0.01 and 0.005. We report the clusters that survived all 3 levels. Similar
technique was also employed by Leritz et al. (Leritz et al., 2011).
2.8. Covariates in the model
In order to improve the variance explained by our predictor of
interest, we added as nuisance covariates, those variables that showed
signiﬁcant relationship with mean whole brain CT (dependent
variable).
There was a signiﬁcant negative correlation between age and mean
whole brain CT (rho = −0.57; p b 0.001). The association between age
and CTwaswidespread bilaterally. We therefore used age as a nuisance
covariate in the model for all analyses. Alcohol use was examined next.
A unit of alcohol here is deﬁned as equivalent to 10 mL or 8 g of pure
alcohol. We found no association between number of alcohol units
consumed per week and mean CT (rho = 0.06; p = 0.68). Alcohol
use was therefore not included as a nuisance covariate in further analy-
ses. Similarly socioeconomic status as measured using the SIMD did
not explain any signiﬁcant variance in mean CT (Mann–Whitney U =
182.0; p = 0.3).
Two other variables – education status and smoking status –were
found to have a signiﬁcant association with the mean whole brain CT.
There was a signiﬁcant positive correlation between number of years
spent in full time education (FTE) and mean whole brain CT (rho =
0.36; p = 0.02). Regionally, greater FTE was associated with greater
CT in the left perisylvian regions. We also found signiﬁcant association
between smoking status and mean whole brain CT (t = 4.17; p =
0.001). The relationship between smoking status and CT was spread
across the cortex bilaterally. However, we also found that in our sample,
FTE showed a positive correlation with the predictor variables LDL
factor (r = 0.24; p = 0.17) and a signiﬁcant negative correlation
with CRP (rho = −0.48; p = 0.002) and ICAM (r = −0.45; p =
0.004) levels. Smoking status was associated with greater ICAM levels
(t = −1.9;p = 0.06) and lower LDL factor (t = 1.9; p = 0.05). We
therefore did not include FTE or smoking status in the initial analysis,
but we conducted a post hoc exploratory analysis of the relationship
between LDL factor, ICAM, CRP, smoking status, FTE and CT. All covari-
ates were examined at p b 0.05.
3. Results
3.1. Classic risk factors
Table 1 shows the demographic and biomarker details of the par-
ticipants in the study. Table 2 shows the result of the PCA—and loading
on each factor. The cluster-wise cortical analysis showed a number of
regions of signiﬁcant association (Fig. 1). Only those for LDL and the
TAG factors remained signiﬁcant after multiple comparison correction.
The regions corresponding to those that survived multiple testing are
labelled with an asterisk in Fig. 1(d and e). Both LDL and TAG factors
showed a signiﬁcant positive association with CT (yellow/orange). The
clusters that survived for the LDL factor were located in the inferior
and middle frontal, precentral gyrus, inferior post central, supra-
marginal and superior temporal cortex on the left hemisphere, and
supramarginal, inferior post central and posterior superior temporal
gyri on the right. TAG factor was associated with CT pertaining to the
medial frontal on the left and medial frontal, middle temporal and
parahippocampal gyrus on the right. Although a few clusters showed
up on initial analysis with HDL factor, CIMT and BMI, none of them sur-
vived multiple testing corrections. Table 3 shows the details of the sig-
niﬁcant clusters that were associated with each risk factor across
various thresholds. Fig. 3 shows the scatter plots of individual predictors
plotted against CT pertaining to themost signiﬁcant voxel that survived
multiple testing corrections.
3.2. Emerging risk factors
Table 1 shows the details of emerging risk factors explored in the
study. The cluster-wise analysis showed a number of regions of signiﬁ-
cant association. Only those for CRP and ICAM remained signiﬁcant after
multiple comparison correction. The regions corresponding to those
that survived multiple testing are labelled in Fig. 2(a and b). CRP and
ICAM showed a signiﬁcant inverse association with CT (blue). Although
a number of regions showed up on initial analysis with the other
inﬂammatory and clotting markers, none of them survived multiple
testing corrections. Some of the associations between the markers and
CT were positive (red). Table 3 shows the details of the signiﬁcant
Table 1
Descriptive statistics — classical and emerging risk factors.
N = 40 Reference Mean Std. deviation
Age (years) – 50.96 8.28
Alcohol units per week – 17.68 16.51
Number prescribed statins – 7
Number of smokers 19
CIMT (mm) .70 .13
BMI (kg/m2) 27.93 4.5
Total cholesterol (mmol/L) b5.0 5.41 .94
Triglycerides (mmol/L) 0.77–1.7 2.01 1.70
VLDL (mmol/L) 0.9–1.8 1.06 .65
LDL (mmol/L) b3.0 3.10 .80
HDL (mmol/L) >1.0 1.24 .29
APO-A1 (g/L) 1.0–2.2 1.40 .25
APO-B (g/L) 0.6–1.3 .99 .21
hsCRP (mg/L)a b1.0 2.14 2.5
ICAM (ng/mL)a 269.90 72.31
IL6 (pg/mL)a 0–14 2.58 4.03
Fibrinogen (g/L)a 3.06 .79
tPA (ng/mL)a 3.5–7.2 4.42 1.85
vWF (IU/dL)a 137.64 44.25
VLDL—very low density lipoprotein; LDL—low density lipoprotein; HDL—high density
lipoprotein; APO—apoprotein; BMI—body mass index; CIMT—carotid intima-media
thickness; ICAM—intercellular adhesion molecules; IL6—interleukin 6; tPA—tissue
plasminogen activator; vWF—von Willebrand factor; hsCRP—C reactive protein.
a n = 39.
Table 2
Rotated factor matrix from PCA of lipid fractions.
Component
TAG factor LDL factor HDL factor
Triglycerides .975 .013 .012
VLDL .955 .045 − .054
LDL − .196 .963 .015
Apo B .293 .932 − .088
HDL − .337 − .103 .920
Apo A1 .240 .025 .958
High factor loadings to the components are depicted in bold.
Extraction method: Principal component analysis.
Rotation method: Varimax with Kaiser normalisation.
VLDL—very low density lipoprotein; LDL—low density lipoprotein; HDL—high density
lipoprotein; APO—apoprotein; BMI—body mass index.
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clusters that were associated with each risk factor across various
thresholds. Fig. 3 shows the scatter plots of individual predictors plotted
against CT pertaining to the most signiﬁcant voxel that survived multi-
ple testing corrections.
3.2.1. Covariate analysis
The relationship between LDL factor, ICAM, CRP and CT remained
even after including FTE as a covariate in the model. However, the
size of the clusters was reduced (Table 4). Similarly, the relationship
between LDL factor, CRP and CT remained even after including
smoking status as a covariate in the model. With LDL, the size of the
clusters reduced, while with CRP, the size of the cluster increased
(Table 4). However, the relationship between and ICAM and CT
disappeared completely when smoking status was added as a covariate
in the model.
4. Discussion
The aim of the paper was to examine the relationship between
cardio-metabolic risk factors and CT. We have shown that in a sample
of healthy middle-aged male subjects, lipid fractions—particularly
those pertaining to TAG, VLDL and LDL explained signiﬁcant variance
in CT across a number of regions in the brain. We have also shown
that inﬂammatory markers, particularly CRP and ICAM-1 explained
signiﬁcant variance in CT across a number of regions in the brain.
4.1. Classic risk factors
While obesity has a strong effect on lipoprotein metabolism,
recent studies have shown that the relationship between BMI and
lipid fractions may not be consistent and therefore, this may indeed
be independent risk factors for cerebrovascular and cardiovascular
Fig. 1. a) BMI—body mass index; b) CIMT—carotid intima-media thickness; c) HDL factor—HDL and Apo A1; d) LDL factor—LDL and Apo B; e) TAG factor—triglycerides and VLDL—*
Only the relationship between LDL factor and cortical thickness and TAG factor levels and cortical thickness survived multiple correction using the Monte Carlo Null-Z simulation
technique. The regions that survived are labelled with * for p b 0.05; ** if p b 0.01 and *** if p b 0.005. The cortical surface is inﬂated, and the dark grey areas represent sulci, and
light grey represents gyri.
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risk (Nicholls et al., 2006; Shamai et al., 2011). Hence the effects of
BMI and cholesterol were examined separately. The results of the
data reduction using PCA enabled us to examine the effect of broad
domains within the markers that are statistically independent. The
factors extracted from PCA were found to be meaningful—HDL
cholesterol and Apo A1 formed a single factor (HDL) and LDL and Apo
B formed a second factor (LDL). Apolipoprotien A1 and Apolipoprotien
B are themajor protein component of HDL and LDL respectively in plas-
ma. VLDL and triglycerides, which contain most of the triglycerides,
formed the third factor (TAG). The density of a lipoprotein that carries
the cholesterol depends on the amount of triglyceride in the fraction.
Thereforewe found that the lipoprotein fractionswith greater triglycer-
ide fraction (TAG, LDL and VLDL)were associatedwith greater CT,while
HDL, which contains the least triglycerides, showed the smallest associ-
ation. While BMI, and HDL showed associations with CT in some
regions, none of these clusters survived multiple testing corrections.
These relationships were contrary to our expectations. We expected
the presence of greater risk factors (LDL and TAG factors) to be associat-
edwith cortical thinning in a number of regions. Ourﬁndings are in con-
trast to a number of previous studies that have found a negative
association between greater risk factors and grey matter morphology.
Both cross sectional and longitudinal studies have shown signiﬁcant
negative association between BMI and regional grey matter volume
(Gunstad et al., 2008; Raji et al., 2010; Walther et al., 2010; Yokum
et al., 2012). Although Ward et al., in their study found no relationship
between non HDL cholesterol and grey matter volume, they found
that thosewith decreased levels of HDL cholesterol showedGM volume
reductions pertaining to a number of cortical and subcortical structures
(Ward et al., 2010). All of the above studies used techniques (voxel/
tensor based morphometry) that do not decompose cortical volume
into thickness and surface area. Cortical volume is a construct that is
derived from two distinct properties of the cortical sheet: CT and
surface area and have distinct cellular and genetic bases (Panizzon
et al., 2009; Rakic, 2009). This highlights the importance of studying
CT independently in morphometric studies, as highlighted recently
(Palaniyappan and Liddle, 2012). Further, CT appears to be highly
susceptible to various environmental inﬂuences such as exposure to
smoking, metabolic risk factors and cannabis, while surface area seems
to be more stable (Habets et al., 2011; Kuhn et al., 2010; Leritz et al.,
2011).
More recent studies that have used similar image analysis techniques
as used in the present study have found interesting results. In the ﬁrst
study, Isaac et al., found a negative association between visceral abdom-
inal fat measured using MRI and CT pertaining to frontal, parietal and
occipital cortices (Isaac et al., 2011). They however, did not measure
lipid fractions in the blood. A second larger study, which examined the
association between CT and peripheral cholesterol levels in an older
population (mean age 68.3 years), found a similar relation to our
study. They found that an increase in cholesterol factor with high load-
ings from total cholesterol and LDL was signiﬁcantly associated with
an increase in CT. However, a second factor which included HDL and
BMI did not show such an association (Leritz et al., 2011). They suggest
that the results in their study could be explained by other studies that
have shown that neurodegeneration (and hence cortical thinning) is as-
sociatedwith lower serum cholesterol due to disruption in brain choles-
terol production (Solomon et al., 2009). The fact that we found a similar
relationship in a smaller sample suggests that the relationship is more
than trivial (Friston, 2012). Our sample was also younger suggesting
that the relationship between risk factors and cortical morphology
may be evident earlier on in life. In another study, the same group has
found higher HDL and LDL cholesterol in normo-lipidemic individuals
to be associated with compromised regional white matter integrity.
These ﬁndings suggest that the relationships between cholesterol,
white matter and grey matter are complex (Williams et al., 2012).
Although it accounts for only 2% of total body weight, the human
brain contains as much as 25% of total body cholesterol. Cholesterol in
the brain is primarily synthesised by glia. It is an essential component
of cell membrane and myelin in the white matter. In this context,
cholesterol abnormalities have been implicated in a number of neuro-
degenerative illnesses, where the primary pathogenesis seems to
involve deregulated cholesterol trafﬁcking (Liu et al., 2010). Leritz
et al. therefore suggest that a bidirectional mechanism between choles-
terol and the brainmay exist, such that higher levels in the brain predis-
pose an individual to havehigher levels in circulating blood (Leritz et al.,
2011). Therefore the positive relationship between cholesterol and CT is
a reverse epiphenomenon. It is also not clear if the association between
CT and peripheral cholesterol level is related to pathological processes.
Consistent with our ﬁndings, more recently, Hoogendam et al. exam-
ined the relationship between cardiovascular risk factors and cerebral
volume measured using FreeSurfer in a community dwelling non-
demented elderly sample of 3962 people. They found that higher total
cholesterol levels were related to a larger cerebral volume. They
found no association between HDL cholesterol and cerebral volume
(Hoogendam et al., 2012).
CIMTmeasured using carotid ultrasound is an efﬁcient and validated
method for assessing the degree of atherosclerosis in an individual.
While previous studies have found an association between CIMT and a
risk of stroke, we did not ﬁnd a relationship between CIMT and CT
(Lorenz et al., 2007). Recently, Cardenas et al. (2012) examined this
relationship in an older sample. Using similar technique to ours, they
Table 3
Details of the clusters that survived the Monte Carlo Z simulation at various thresholds.
Risk factor Threshold
p value
Cluster no Region Size of cluster
(mm2)
Tal X Tal Y Tal Z Number
of vertices
LDL factor 0.05 1 Lh superior frontal 16225.72 −11.5 −7.7 47.3 34,785
0.01 1 Lh precentral 2997.09 −57.2 −0.1 10.7 6863
0.005 1 Lh precentral 2290.76 −57.2 −0.1 10.7 5209
0.05 1 Rh banks sts 9061.66 45.9 −43.8 7.5 20,217
TAG factor 0.05 1 Lh superior frontal 4291.85 −6.6 33.8 49.8 6781
0.05 1 Rh precentral 9071.69 27.7 −14.4 60.2 15,680
0.05 2 Rh superior temporal 5446.62 47.5 5.0 −27.2 9395
0.01 1 Rh rostral middle frontal 3269.26 27.7 57.8 −9.5 4964
0.01 2 Rh superior temporal 2343.63 47.5 5.0 −27.2 3610
0.005 1 Rh superior frontal 2064.68 9.3 41.1 30.0 3149
0.005 2 Rh superior temporal 1701.21 47.5 5.0 −27.2 2572
hsCRP 0.05 1 Lh precentral 6662.41 −57.2 −0.1 10.7 14,860
0.01 1 Lh post central 1543.87 −62.6 −15.0 19.0 3489
ICAM 0.05 1 Lh precentral 4890.49 −57.2 −0.1 10.7 11,789
0.01 1 Lh superior temporal 2134.62 −52.1 −24.0 −4.0 5232
0.005 1 Lh supramarginal 1353.83 −48.6 −28.2 19.3 3334
Tal—Talairach coordinates of the vertex corresponding to the strongest association; Lh—left hemisphere; Rh—right hemisphere; hsCRP—C-reactive protein; b) ICAM—intercellular
adhesion molecule; LDL factor—LDL and Apo B; TAG factor—VLDL and TAG.
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found no relationship between CIMT and most measures of brain
volume or CT (Cardenas et al., 2012). They however found CIMT to be
associated with regional thinning pertaining to the parietal cortex. In
their analysis, they divided the whole cortex into lobes, considering
each lobe separately as a region of interest. This may have increased
the power to detect subtle changes in individual lobes. None of the
clusters survivedmultiple corrections in our sample. This may however
be due to our small sample size.
4.2. Emerging risk factors
There is a growing body of evidence linking peripheral inﬂamma-
tory markers to brain structure and function. Molecular imaging stud-
ies have shown that peripheral inﬂammation immune/metabolic
markers are directly associated with greater inﬂammation markers
in the brain. Drake et al. used PET tracer PK 11195 to examine the re-
lationship between cerebrovascular risk factors (but no stroke) and
Fig. 2. a) hsCRP—C-reactive protein; b) ICAM—intercellular adhesion molecule; c) ﬁbrinogen; d) IL6—interleukin 6; e) tPA—tissue plasminogen activator; f) vWF—von Willebrand
factor. Only the relationship between ICAM and cortical thickness and IL-6 levels and cortical thickness in the lateral aspects of the brain survived multiple correction using the
Monte Carlo Null-Z simulation technique. The regions that survived are labelled. The cortical surface is inﬂated, and the dark grey areas represent sulci, and light grey represents
gyri.
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brain inﬂammation. They found that people with greater risk factors
showed greater microglial activation in the brain, compared to normal
controls (Drake et al., 2011). Similarly, a few studies have shown that
modulating peripheral inﬂammation is associated with both functional
and structural changes in the brain. Harrison et al. showed that inducing
a peripheral inﬂammatory response using typhoid vaccine in normal
adults is associated with change in bold signals in regions pertaining to
modulation of mood in the brain (Harrison et al., 2009). More recently,
Hannestad et al. found that systemic inﬂammation induced by endotoxin
in humanswas associatedwith higher normalised glucosemetabolism in
the insula. This change was associated with change in peak cytokine
levels and also changes in social interest, suggesting that these may be
linked to each other (Hannestad et al., 2012). We have previously
shown that modulating peripheral inﬂammation in patients with rheu-
matoid arthritis, using adalimumab (a TNF inhibitor) is associated with
a reduction in serotonin transporter availability in the brain (Cavanagh
et al., 2010). A few structural MRI studies have shown an association
between inﬂammatory markers and cortical and subcortical grey matter
volume. Jefferson et al. in the Framingham cohort showed that inﬂam-
matory markers including IL6 were inversely associated with total
brain volume (Jefferson et al., 2007). Marsland et al., showed an associa-
tion between peripheral IL-6 levels and smaller grey matter volume in
the hippocampus inmiddle aged adults (Marsland et al., 2008). Although
we found an association between IL6 levels and CT pertaining to the
parahippocampal gyrus, these clusters did not survive multiple testing
corrections.
Our ﬁndings reﬂect those of a more recent study that found an asso-
ciation between hsCRP and cortical grey matter volume pertaining to
perisylvian regions in a large cohort of healthy ageing subjects (Taki et
al., 2012). We have replicated the ﬁnding in a smaller and younger sam-
ple. However, our clusters weremore extensive than those described by
the study. While most of the above studies have shown an inverse rela-
tionship between peripheralmarkers and corticalmorphology, a few re-
cent studies have suggested that the relationship between peripheral
risk factors and cortical morphology may be more complex than earlier
thought. For example, greater peripheral blood levels of TGF beta, an ap-
optotic and anti-proliferative factor have been associated with greater
CT (Piras et al., 2012). We found similar relationships in the case of
ﬁbrinogen, IL6 and a few other clusters in other markers. None of them
however survived multiple testing corrections, suggesting that the rela-
tionship between them and CTmay not be as robust for these measures.
However, this could be due to type 2 error due to the small sample size.
To our knowledge, no previous study has shown an association be-
tween ICAM-1 and CT. ICAM-1 is an adhesion molecule expressed by
Fig. 3. Scatter plots of relationship between cortical thickness and risk factors. Scatter plots pertaining to the vertex showing the strongest association are shown. Those prescribed
statins are shown in blue. Details of the clusters and vertex location are shown in Table 2.
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endothelial cells in response to inﬂammation—particularly pro-
inﬂammatory cytokines like tumour necrosis factor (TNF) (which
also is a potent stimulator of CRP) and physiological stress (Dietrich,
2002; Frank and Lisanti, 2008). Inﬂammatory activation of ICAM-1
has been shown to be associated with an increase in leukocyte migra-
tion and region speciﬁc (frontal and parietal) microglial activation in
the brain (Dietrich, 2002; Huber et al., 2006). While this has mostly
been demonstrated in primary inﬂammatory conditions of the brain,
there are few studies examining the role of ICAM-1 in situations
where inﬂammatory pathology is lessmanifested likemajor depression
(Krishnadas and Cavanagh, 2012). A recent study has shown that selec-
tive serotonin reuptake inhibitors (SSRIs), medications primarily used
in the treatment of depression, may have cardio-protective properties
by directly inhibiting TNF induced ICAM-1 expression (Lekakis et al.,
2010). The clusters in our study that correlated with CRP and ICAM-1
were in the inferior frontal and parietal cortices similar to that shown
by Dietrich (2002). While we could postulate that these ﬁndings
could represent a region speciﬁc relation between peripheral inﬂamma-
tory and cell adhesion markers and the brain, causal assumptions
cannot be made due to the cross sectional nature of our data.
4.3. Exploring covariates in the model
We found a signiﬁcant positive relationship between education
status and CT. This is similar to previous studies (Liu et al., 2012).
Since education status was also related to LDL, ICAM and CRP, we ex-
plored the relationship between the above predictors and CT with edu-
cation status as a potential covariate. All the predictors remained
signiﬁcantly associatedwith CThowever, the strength of someof the re-
lationships reduced, denoted by a reduction in the cluster size,
suggesting that at least part of the variance explained by education sta-
tus and the risk factors were shared. With regard smoking we found a
signiﬁcantly strong negative association between smoking status and
CT, similar to previous studies (Kuhn et al., 2010). Just as education sta-
tus, smoking status also showed signiﬁcant association with LDL, ICAM
and CRP. Surprisingly, the relationship between smoking status and LDL
cholesterolwas contrary to previous studies (Habets et al., 2011). Those
who smoked had lower LDL cholesterol. The relationship between
CRP and CT remained signiﬁcant even with smoking status as covariate
in the model. However, the relationship between ICAM and CT
disappeared. This suggests that almost all of the variance explained by
ICAM and CT was shared with smoking status. Theoretically we could
argue that greater ICAM levels may be statistically mediating the rela-
tionship between smoking and CT. Smoking has indeed been shown
to induce adhesion molecules in both pulmonary and peripheral blood
(Noguchi, 1999; Schaberg et al., 1996). While this is mechanistically
plausible, causal mediation cannot be attributed to our ﬁndings due to
the cross sectional nature of the study.
Seven subjects in our study were prescribed statins. It could be
argued that thosewith greater cholesterol were prescribedwith statins,
which have anti-inﬂammatory properties and may have contributed to
an increase in regional CT. Our sample was underpowered to examine
the effect of statin intake. On examining the scatter plot, in general,
the distribution of those on statins was similar to those not on statins.
However, at least in certain cases (TAG and ICAM), there seems to be
an interaction between statin intake status and the relationship
between the variables and cortical thickness. Our result differs from
the previous study that used similar technique to ours and showed no
effect of medication on CT. They found that the association was purely
due to the cholesterol factor itself (Leritz et al., 2011). The relationship
betweenmedication status and CT should be further explored in studies
with larger sample size.
4.4. Relevance of measuring the association between cardiovascular risk
markers and cortical morphology
Quantifying the variance in cortical parameters that could be attrib-
utable to risk markers in health and illness is key to the understanding
of the relationship between cardiovascular health and neural health. As
mentioned above, PET studies have shown that greater levels of cardio-
vascular risk markers in the peripheral blood are associated with
greater microglial activation in neurologically normal subjects (Drake
et al., 2011). This suggests that pathophysiological processes are in
play even in normal subjects who are at high risk of developing cardio/
cerebrovascular diseases. Interestingly, psychiatric morbidity is often as-
sociated with greater cardiovascular risk and mortality. While this has
traditionally been attributed to poor health choices and health care
utilisation by this population, recent research suggests that such simplis-
tic modelling of physical health co-morbidities or multi-morbidity may
not be useful and may indeed be misleading (de Jonge and Roest,
2012). There is now a call to examine the role of cardiovascular andmet-
abolic risk markers as common endophenotypes of both physical and
psychiatric illnesses. In other words, there may be common genetic
and environmental factors that may contribute to chronic metabolic
illnesses like obesity and psychiatric illnesses like major depression
(Bornstein et al., 2006). The link between peripheral cardiovascular risk
markers and cortical thickness in our study may therefore be the inde-
pendent phenotypic representation of a common genes or environment.
It is now known that the brain is not an immune privileged organ, and
proinﬂammatory cytokines like TNF alpha, which are potent stimulators
of CRP, are also produced by astrocytes and microglia within the central
nervous system and are important in synapse formation and synaptic
neurotransmission and in turn neurocognitive function (McAfoose and
Baune, 2009). Indeed, there is increasing evidence that inﬂammatory
markers contribute to the pathophysiology of psychiatric illnesses
(Krishnadas and Cavanagh, 2012).
Table 4
Details of the clusters that survived after including smoking status or education status as covariates.
Risk factor Region Maxima
(negative log of p value)*
Size of cluster
(mm2)
Tal X Tal Y Tal Z Number
of vertices
Covariate: Smoking status
LDL factor Lh precentral 4.00 9736 −57.2 −0.1 10.7 22,012
Rh rostral middle frontal 3.39 4587.95 43.7 24.0 28.2 10,309
CRP Lh precentral −4.00 7715.55 −57.2 −0.1 10.7 17,163
ICAM –
Covariate: Education status
LDL factor Lh precentral 4.00 13069.22 −57.2 −0.1 10.7 28,224
Rh supramarginal 3.15 4438.65 55.1 −38.4 27.5 10,719
CRP Lh precentral −2.85 4531.2 4 −52.5 −6.6 38.5 10,086
ICAM Lh insula −2.01 3502.00 −32.4 −31.9 17.1 8525
Tal—Talairach coordinates of the vertex corresponding to the strongest association; Lh—left hemisphere; Rh—right hemisphere; *survived p b 0.05 Monte Carlo Z simulation; hsCRP
—C-reactive protein; b) ICAM—intercellular adhesion molecule; LDL factor—LDL and Apo B.
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More importantly, the lack of progress in developing effective
treatments in psychiatry has led to the search for markers that may
aid diagnosis or predict treatment response in what are highly hetero-
geneous conditions (Krishnadas and Cavanagh, 2012). Recently there
has been an emphasis on combining imaging markers with peripheral
blood risk markers in order to identify what may provide a “biological
signature” that may help predict treatment response (Linden, 2012;
Schmidt et al., 2011).
Exploring the relationship between cardio-metabolic risk factors
and corticalmorphology can also give us clues as to the pathophysiolog-
ical link between high risk environmental situations like poor socioeco-
nomic status (SES) and mental illnesses. For example, SES has been
consistently associated with cognitive and mental health—which is
thought to be the result of coordinated activity of large-scale networks
across the whole cortex. SES has also been associated with greater
cardio metabolic risk. Therefore an emerging question is whether the
association between SES and cortical substrates of neurocognitive func-
tions ismediated by the presence of greater cardio-metabolic risk in this
population. Current evidence suggests that cumulative (both in time
and across multiple physiological systems) physiological risk across
the life span associatedwith socioeconomic deprivationmay contribute
to bothmental and physical health over the life span (Gruenewald et al.,
2012). McEwen et al. describe a process of allostasis, where physiolog-
ical systems operate within and outside a given range of parameters
in order to maintain homeostasis (McEwen and Seeman, 1999). In
this context, “allostatic load” is thought to be the wear and tear that
the body experiences as a result of activation of the above systems.
Thiswear and tear represents either the ‘excess’ or the ‘inefﬁcient’ oper-
ation of the above physiological systems. It is not surprising that,
in this context, metabolic and inﬂammatory systems play a key role in
the process of allostasis. A number of studies have shown a signiﬁcant
association between allostatic load (measured using a composite
score of inﬂammatory and metabolic markers) and medical health
(for e.g. cardiovascular disease) and neurocognitive function(Juster
et al., 2010). These potential mechanisms may provide insight into
how chronic adversity can affect physical and mental wellbeing (Kin
et al., 2007). It is therefore reasonable to quantify any association
between cardiovascular health and neural health in terms of gross
cortical morphology.
4.5. Limitations
While the positive features of this study include awell-characterised
community-based cohort, there are limitations to be acknowledged,
there is some selection bias in that the participants opted in. We delib-
erately included only males in our study. The rationale behind this was
to decrease variability in CT that could be attributable to gender (Sowell
et al., 2007). Similarly, cardio-metabolic risk factors covary signiﬁcantly
with gender. For example, during the third and fourth decade of life,
cholesterol levels show a sharper increase in men than in women. In
addition, the same cardiovascular risk factors may impact differently
on men and women. For example, HDL cholesterol and Triglycerides
have been found to have a greater impact on cardiovascular disease
risk in women compared to men (Roeters van Lennep et al., 2002).
However, this meant that the ﬁndings of our study are less generaliz-
able to the population. The parent study – PSOBID – was designed to
explore the differences in a number of biomarkers between the least
and most deprived groups with the greatest power. Therefore, the
nature of the sampling technique used for recruiting subjects led to a
bimodal distribution of a number of independent variables used in
this study. However, CT (the dependent variables) did not differ
between the most and the least deprived groups. Indeed, the mean CT
(contributed by the DV) was normally distributed. Nevertheless, a sam-
pling technique with equal distribution from all socioeconomic status
with a larger sample size may have been more appropriate, in order
to explore a dose dependent relationship between cardio-metabolic
risk markers and CT. With regards multiple testing correction, we
used the cluster wise approach when examining the relationship
between risk markers and cortical thickness. This approach has been
validated and used in recent studies exploring variance in cortical thick-
ness (Ehrlich et al., 2012; Leritz et al., 2011).Weopted for this approach,
as the primary aim of our study was to look for any evidence for a
“signal” in the cortex that could be attributable to the risk markers.
For this, a cluster wise approach was thought to be sensitive and appro-
priate (Poldrack et al., 2011). We were not primarily interested in the
spatial speciﬁcity or location of the signiﬁcant clusters, and hence did
not opt for a voxel wise approach. While this is not a limitation per se,
when we repeated our analysis using a voxel wise FDR (0.05) approach
for multiple testing corrections, none of the above regions survived the
FDR correction. In other words, the test statistic at none of the voxels
crossed the required signiﬁcance threshold after multiple testing
corrections using the FDR procedure. This could be either due to the
small sample size or due to the fact that the relationship between the
risk markers and the cortical thickness is spread across the cortex, but
the magnitude of the relationship is modest at best. Previous cross
sectional studies suggest that cerebrovascular disease may mediate
the relationship between cardiovascular risk factors like diabetes and
hypertension and cortical thickness in cognitively impaired individuals
(Seo et al., 2012a, 2012b). It is therefore possible that the relationship
between high CRP and ICAM and cortical thinning in our studywasme-
diated by the presence of cerebrovascular pathology. Noneof our partic-
ipants showed signiﬁcant pathology on the scans. Moreover, the small
sample size and the cross sectional nature of our data precludes us
from making any meaningful conclusions regarding the role of causal
mediation or mediators. In addition, greater LDL and TAG factor levels
(generally associated with greater cardiovascular risk) were associated
with greater cortical thickness. It is unlikely that this relationship was
mediated by cerebrovascular pathology in our sample. In order to
explore the role of causal mediators in this complex relationship, our
ﬁndings should be replicated in larger study with greater variation in
peripheral risk markers and a longitudinal design. Further work should
also involve replication of the study in a larger population, including
younger population, targeting critical periods of brain growth. Finally,
future work to develop a clearer biological framework of a more com-
prehensive investigation of metabolic and inﬂammatory markers may
be more informative.
5. Conclusion
In conclusion, this study has demonstrated the existence of a rela-
tionship between classic and emerging cardiovascular risk factors and
CT involving a number of regions in the brain. The ﬁndings reinforce a
body of existing literature increasingly showing a link between cardio-
vascular risk factors and the brain. A focussed investigation of factors
determining inter-individual variations in regional CT in the adult
brain could provide further clarity in our understanding of the relation-
ship between various determinants of cardio-metabolic risk and cortical
structures.
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